Avivi, Irit <br/><br/>
Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.  [electronic resource] 

 -  American journal of hematology  May 2013 
 - 400-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1096-8652 
<br/><br/><label>Standard No.: </label>10.1002/ajh.23423  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cohort Studies<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>False Negative Reactions<br/>Female<br/>Fluorodeoxyglucose F18<br/>Follow-Up Studies<br/>Humans<br/>Lymphoma, Large B-Cell, Diffuse--diagnosis<br/>Male<br/>Middle Aged<br/>Multimodal Imaging<br/>Positron-Emission Tomography<br/>Predictive Value of Tests<br/>Prednisone--administration & dosage<br/>Radiopharmaceuticals<br/>Recurrence<br/>Remission Induction<br/>Retrospective Studies<br/>Rituximab<br/>Tomography, X-Ray Computed<br/>Vincristine--administration & dosage